These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35512420)

  • 1. Design, synthesis and biological activity evaluation of a series of bardoxolone methyl prodrugs.
    Liu L; Pan X; Xie F; Xu X; Xiao D; Xiao J; Zhou X
    Bioorg Chem; 2022 Jul; 124():105831. PubMed ID: 35512420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Derivative of Bardoxolone Methyl Improves Safety for the Treatment of Diabetic Nephropathy.
    Huang Z; Mou Y; Xu X; Zhao D; Lai Y; Xu Y; Chen C; Li P; Peng S; Tian J; Zhang Y
    J Med Chem; 2017 Nov; 60(21):8847-8857. PubMed ID: 28994286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Point Mutation at C151 of
    Gatbonton-Schwager T; Yagishita Y; Joshi T; Wakabayashi N; Srinivasan H; Suzuki T; Yamamoto M; Kensler TW
    Mol Pharmacol; 2023 Aug; 104(2):51-61. PubMed ID: 37188495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and quantification of the basal and inducible Nrf2-dependent proteomes in mouse liver: biochemical, pharmacological and toxicological implications.
    Walsh J; Jenkins RE; Wong M; Olayanju A; Powell H; Copple I; O'Neill PM; Goldring CE; Kitteringham NR; Park BK
    J Proteomics; 2014 Aug; 108(100):171-87. PubMed ID: 24859727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bardoxolone methyl (CDDO-Me) as a therapeutic agent: an update on its pharmacokinetic and pharmacodynamic properties.
    Wang YY; Yang YX; Zhe H; He ZX; Zhou SF
    Drug Des Devel Ther; 2014; 8():2075-88. PubMed ID: 25364233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a new azoreductase driven prodrug from bardoxolone methyl and 5-aminosalicylate for the treatment of colitis in mice.
    Qiao X; Gong Y; Mou Y; Zhang YH; Huang ZJ; Wen XD
    Chin J Nat Med; 2021 Jul; 19(7):545-550. PubMed ID: 34247779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bardoxolone methyl inhibits the infection of rabies virus via Nrf2 pathway activation in vitro.
    Chi YL; Xie Y; Liu SQ; Zhu WY
    Virol J; 2023 Nov; 20(1):258. PubMed ID: 37950261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bardoxolone methyl prevents metabolic dysfunction-associated steatohepatitis by inhibiting macrophage infiltration.
    Onuma K; Watanabe K; Isayama K; Ogi S; Tokunaga Y; Mizukami Y
    Br J Pharmacol; 2024 Aug; 181(15):2545-2565. PubMed ID: 38599607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CDDO-Me Attenuates Vasogenic Edema and Astroglial Death by Regulating NF-κB p65 Phosphorylations and Nrf2 Expression Following Status Epilepticus.
    Kim MJ; Park H; Choi SH; Kong MJ; Kim JE; Kang TC
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31574956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bardoxolone methyl induces apoptosis and autophagy and inhibits epithelial-to-mesenchymal transition and stemness in esophageal squamous cancer cells.
    Wang YY; Yang YX; Zhao R; Pan ST; Zhe H; He ZX; Duan W; Zhang X; Yang T; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():993-1026. PubMed ID: 25733817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The synthetic triterpenoids CDDO-TFEA and CDDO-Me, but not CDDO, promote nuclear exclusion of BACH1 impairing its activity.
    Casares L; Moreno R; Ali KX; Higgins M; Dayalan Naidu S; Neill G; Cassin L; Kiib AE; Svenningsen EB; Minassi A; Honda T; Poulsen TB; Wiel C; Sayin VI; Dinkova-Kostova AT; Olagnier D; de la Vega L
    Redox Biol; 2022 May; 51():102291. PubMed ID: 35313207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bardoxolone Methyl Suppresses Hepatitis B Virus Large Surface Protein Variant W4P-Related Carcinogenesis and Hepatocellular Carcinoma Cell Proliferation Via the Inhibition of Signal Transducer and Activator of Transcription 3 Signaling.
    Gee MS; Kang SB; Kim N; Choi J; Kim NJ; Kim BJ; Inn KS; Lee JK
    Pharmacology; 2018; 102(1-2):105-113. PubMed ID: 29953997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Effects of Nrf2 Activation by Bardoxolone Methyl in Chronic Heart Failure.
    Tian C; Gao L; Zhang A; Hackfort BT; Zucker IH
    J Pharmacol Exp Ther; 2019 Dec; 371(3):642-651. PubMed ID: 31601682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bardoxolone methyl modulates efflux transporter and detoxifying enzyme expression in cisplatin-induced kidney cell injury.
    Atilano-Roque A; Aleksunes LM; Joy MS
    Toxicol Lett; 2016 Sep; 259():52-59. PubMed ID: 27480280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and Anticancer Activity of CDDO and CDDO-Me, Two Derivatives of Natural Triterpenoids.
    Borella R; Forti L; Gibellini L; De Gaetano A; De Biasi S; Nasi M; Cossarizza A; Pinti M
    Molecules; 2019 Nov; 24(22):. PubMed ID: 31766211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of ex vivo CDDO-Me activation on nuclear factor erythroid 2-related factor 2 pathway in white blood cells from patients with septic shock.
    Noel S; Zheng L; Navas-Acien A; Fuchs RJ
    Shock; 2014 Nov; 42(5):392-9. PubMed ID: 25105464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dimethyl fumarate and the oleanane triterpenoids, CDDO-imidazolide and CDDO-methyl ester, both activate the Nrf2 pathway but have opposite effects in the A/J model of lung carcinogenesis.
    To C; Ringelberg CS; Royce DB; Williams CR; Risingsong R; Sporn MB; Liby KT
    Carcinogenesis; 2015 Jul; 36(7):769-81. PubMed ID: 25939751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CDDO-Me, Sulforaphane and tBHQ attenuate the RANKL-induced osteoclast differentiation via activating the NRF2-mediated antioxidant response.
    Xue P; Hu X; Powers J; Nay N; Chang E; Kwon J; Wong SW; Han L; Wu TH; Lee DJ; Tseng H; Ko CC
    Biochem Biophys Res Commun; 2019 Apr; 511(3):637-643. PubMed ID: 30826055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Methyl Ester of 2-Cyano-3,12-Dioxooleana-1,9-Dien-28-Oic Acid Reduces Endometrial Lesions Development by Modulating the NFkB and Nrf2 Pathways.
    Siracusa R; D'Amico R; Cordaro M; Peritore AF; Genovese T; Gugliandolo E; Crupi R; Impellizzeri D; Cuzzocrea S; Fusco R; Di Paola R
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33924360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro study on effect of bardoxolone methyl on cisplatin-induced cellular senescence in human proximal tubular cells.
    Kurosaki Y; Imoto A; Kawakami F; Ouchi M; Morita A; Yokoba M; Takenaka T; Ichikawa T; Katagiri M; Nielsen R; Ishii N
    Mol Cell Biochem; 2022 Mar; 477(3):689-699. PubMed ID: 34973124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.